| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| 08/3/2022 |
Chief Risk Officer
Trans History: 5
|
Chief Risk Officer | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,800 | $40.95 | 6,406 |
| 08/3/2022 |
Executive Vice President
Trans History: 53
|
Executive Vice President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,500 | $40.95 | 52,392 |
| 08/3/2022 |
President
Trans History: 206
|
President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $40.95 | 83,489 |
| 01/13/2020 |
Chief Information Officer
Trans History: 111
|
Chief Information Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | -- | $41.06 | 93 |
| 01/13/2020 |
CFO & COO
Trans History: 305
|
CFO & COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | -- | $41.06 | 2,127 |
| 03/1/2017 |
Director
Trans History: 175
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 40 | $41.08 | 35,674 |
| 03/1/2017 |
Director
Trans History: 207
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $41.08 | 33,493 |
| 12/31/2022 |
Director
Trans History: 63
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 494 | $41.11 | 19,764 |
| 12/31/2022 |
Director
Trans History: 12
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 437 | $41.11 | 3,510 |
| 12/31/2022 |
Director
Trans History: 26
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 456 | $41.11 | 130,732 |
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.